This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone quarter ended 30 Sep 2026: revenue Rs 515.14 lakh, PAT Rs 12.75 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 1.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended 30 September 2026: revenue from operations was Rs 515.14 lakh and profit after tax of Rs 12.75 lakh. No prior-year quarter data was given, so growth cannot be assessed. For the six months ended 30 September 2026, revenue was Rs 919.78 lakh and profit after tax Rs 23.59 lakh. Six-month operating cash flow was Rs 229.47 lakh. Borrowings and debt-equity were nil, and related-party transactions were confirmed.
Positive profit and operating cash flow support sentiment, but missing prior-year figures limit growth visibility. No debt reduces financial risk.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹5.15 Cr | ₹2.81 Cr | +83.2% |
| Operating profit | ₹0.06 Cr | −₹0.02 Cr | turned positive |
| Profit after tax | ₹0.13 Cr | ₹0.09 Cr | +35.5% |
| EBITDA margin | 1.3% | -0.7% | +2.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.